Media
Category: Press
Filter by
Press
Dipharma announces FDA acceptance of abbreviated new drug application (ANDA) of generic NITISONE for review
Chiasso, Switzerland, January 24th, 2019 – Dipharma S.A. (“Dipharma”) today announced that the U.S. Food and Drug Administration (FDA) accepted its...
Press
Dipharma announces grant of centralised marketing authorization for generic Miglustat in Europe
Chiasso, Switzerland, February 20th, 2019 – – Dipharma S.A. (“Dipharma”) today announced that the European Commission has granted Marketing Authori...
Press
Amerigen and Dipharma announce U.S. FDA approval for generic MIGLUSTAT 100 mg capsules
The first generic version of Miglustat is now approved in the U.S. Lyndhurst, N.J. and Chiasso, Switzerland. April 18th, 2018 – Amerigen Phar...
Press
Dipharma announces the validation of DISANIT® (NITISONE) marketing authorization application in Europe
The first stable capsule formulation of Nitisinone for the treatment of hereditary Tyrosinemia type-1 (HT-1) is now under marketing authorization (...
Press
DIPHARMA and ALVOGEN announce launch of Diterin® 100mg tablets in South Korea
First drug now registered and commercially available in the Republic of South Korea for the treatment of Hyperphenylalaninemia (HPA) due to Phenylk...
English
Deutsch